抽吸方式对卷烟主流烟气氨释放量的影响

为考察抽吸方式对卷烟主流烟气中氨释放量的影响,采用ISO、Massachusetts和Health Canada 3种抽吸方案分别抽吸了15种国产卷烟,然后采用离子色谱法测定了这些卷烟主流烟气中氨的释放量.结果表明:①对于滤嘴打孔卷烟,与ISO抽吸方案相比,采用Massachusetts抽吸方案,混合型卷烟主流烟气中氨...     

基于智能网络与虚拟化计算的移动办公系统信息安全的研究与应用简

本文基于政府行业3G网络和云计算环境移动办公系统的应用实例,重点讨论了构建以网络通信、区域边界、云计算环境、安全管控中心为基础的信息安全平台,为移动办公系统提供一个安全稳定的可信可控可管的移动应用环境的可行性,     

Preparation of pH‐sensitive poly(vinyl alcohol‐g‐methacrylic acid) and poly(vinyl alcohol‐g‐acrylic acid) hydrogels by gamma ray irradiation and their insulin release behavior

A series of pH‐responsive hydrogels were studied as potential drug carriers for the protection of insulin from the acidic environment of the stomach before releasing in the small intestine. Hydrogels based on poly(vinyl alcohol) networks grafted with acrylic acid or methacrylic acid were prepared by a two‐step process. Poly(vinyl alcohol) hydrogels were prepared by gamma ray irradiation (50 kGy) and then followed by grafting either acrylic acid or methacrylic acid onto these poly(vinyl alcohol) hydrogels with subsequent irradiation (5–20 kGy). These graft hydrogels showed pH‐sensitive swelling behavior and were used as carriers for the controlled release of insulin. The in vitro release of insulin was observed for the insulin‐loaded hydrogels in a simulated intestinal fluid (pH 6.8) but not in a simulated gastric fluid (pH 1.2). The release behavior of insulin in vivo in a rat model confirmed the effectiveness of the oral delivery of insulin to control the level of glucose. © 2003 Wiley Periodicals, Inc. J Appl Polym Sci 91: 636–643, 2004     

变量齿轮泵的新机制研究与微圆槽的卸荷能力分析

为实现功率和排量的同步变化以节省资源,提出一款齿轮泵变量的新机构,该机构原理简单,由变量弹簧力和高压油压力的动态平衡驱动齿轮副有效啮合宽度的自动变化,从而实现泵功率和排量随有效啮合宽度的同步变化;并就其困油性能与困油卸荷进行深入研究和分析,提出具有微圆结构的卸荷槽;最后,进行实例运算和分析。结果表明:微圆卸荷槽具有更大的卸荷面积和卸荷能力;有效啮合宽度越小,困油压力峰值越小,困油性能越好;反之,困油性能越差,但影响不大。     

Synthesis of nanoporous Baghdadite by a modified sol-gel method and its structural and controlled release properties

In this research, a bimodal nanoporous Baghdadite (NB) (Ca3ZrSi2O9) was prepared by a modified sol-gel method using P123 as a surfactant. The effects of P123's contents on the structural and textural properties as well as the drug delivery behavior of NB were assessed in vitro. The usage of P123 offered a new route for the synthesis of NB. The synthesized NB samples with different amounts of P123 were studied through X-ray diffraction (XRD), Fourier transform infrared spectra (FTIR), N2 adsorption-desorption, field emission scanning electron microscopy (FESEM) equipped with energy-dispersive X-ray analysis spectroscopy (EDAX) and transmission electron microscopy (TEM). The results showed that a single-phase Baghdadite was obtained by this new method at the calcination temperature of 800?°C. It was found that an increase in P123's content up to 0.025?mol changed the morphology of NB samples from mountain-like to needle-like. The potential application of NB samples as drug delivery agents was assessed by estimating their release properties up to 240?h. This research revealed that the synthesized Baghdadite could be used as a potential nanoporous carrier with controlled release capability in bone tissue regeneration.     

Sustainable Stabilizer-Free Nanoparticle Formulations of Valsartan Using Eudragit® RLPO

The bioavailability of the antihypertensive drug valsartan can be enhanced by various microencapsulation methods. In the present investigation, valsartan-loaded polymeric nanoparticles were manufactured from Eudragit^® RLPO using an emulsion–solvent evaporation method. Polyvinyl alcohol (PVA) was found to be a suitable stabilizer for the nanoparticles, resulting in a monodisperse colloid system ranging in size between 148 nm and 162 nm. Additionally, a high encapsulation efficiency (96.4%) was observed. However, due to the quaternary ammonium groups of Eudragit^® RLPO, the stabilization of the dispersion could be achieved in the absence of PVA as well. The nanoparticles were reduced in size (by 22%) and exhibited similar encapsulation efficiencies (96.4%). This more cost-effective and sustainable production method reduces the use of excipients and their expected emission into the environment. The drug release from valsartan-loaded nanoparticles was evaluated in a two-stage biorelevant dissolution set-up, leading to the rapid dissolution of valsartan in a simulated intestinal medium. In silico simulations using a model validated previously indicate a potential dose reduction of 60–70% compared to existing drug products. This further reduces the expected emission of the ecotoxic compound into the environment.     

Development of Covalent Chitosan-Polyethylenimine Derivatives as Gene Delivery Vehicle: Synthesis,Characterization, and Evaluation

There is an increasing interest in cationic polymers as important constituents of non-viral gene delivery vectors. In the present study, we developed a versatile synthetic route for the production of covalent polymeric conjugates consisting of water-soluble depolymerized chitosan (dCS; M_W 6–9 kDa) and low molecular weight polyethylenimine (PEI; 2.5 kDa linear, 1.8 kDa branched). dCS-PEI derivatives were evaluated based on their physicochemical properties, including purity, covalent bonding, solubility in aqueous media, ability for DNA condensation, and colloidal stability of the resulting polyplexes. They were complexed with non-integrating DNA vectors coding for reporter genes by simple admixing and assessed in vitro using liver-derived HuH-7 cells for their transfection efficiency and cytotoxicity. Using a rational screening cascade, a lead compound was selected (dCS-Suc-LPEI-14) displaying the best balance of biocompatibility, cytotoxicity, and transfection efficiency. Scale-up and in vivo evaluation in wild-type mice allowed for a direct comparison with a commercially available non-viral delivery vector (in vivo-jetPEI). Hepatic expression of the reporter gene luciferase resulted in liver-specific bioluminescence, upon intrabiliary infusion of the chitosan-based polyplexes, which exceeded the signal of the in vivo jetPEI reference formulation by a factor of 10. We conclude that the novel chitosan-derivative dCS-Suc-LPEI-14 shows promise and potential as an efficient polymeric conjugate for non-viral in vivo gene therapy.     

Preparation of Adrenochrome Hydrogel Patch, Gel, Ointment, and the Comparison of Their Blood Coagulating and Wound Healing Capability

The aim of this study is to make an effective blood coagulant and wound healing agent, which on its topical application on ruptured skin would help in instant coagulation of blood and ongoing healing of wound. The hydrogel has been prepared by mixing 28% w/v gelatin and 21% w/v PVA in distilled water, and heated to 40°C followed by addition of a blood coagulant at a lower temperature. Beeswax, alcohol, liquid paraffin, and adrenochrome were mixed, triturated, and heated accordingly to prepare adrenochrome ointment. Polyvinyl alcohol and glycerin were mixed and heated and the drug was added at a lower temperature, and stored at 4-5°C to form adrenochrome gel. Gelatin alone has cell adhesion property. Adrenochrome is a blood coagulant. Therefore, gelatin with adrenochrome in hydrogel has a synergistic effect in wound healing. To evaluate the efficacy of these three different formulations, incisions were made on the backs of three mice and simultaneously adrenochrome containing hydrogel patch, gel, and ointment were applied on the wound and observed at regular intervals for half an hour to examine the rate of blood coagulation and kept under observation for 2 days to study the rate of wound healing. The efficacy of all these three formulations was compared to appraise the most effective blood coagulating and wound healing agent.     

Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery

This review is focused on the two avenues of development that promise a major impact on future ocular drug therapeutics: bioadhesives, including hydrogels and other agents like carbopols, polyacrylic acids, chitosan, etc., and penetration enhancers, including different surfactants, calcium chelators, etc. The capacity of some polymers to adhere to the mucin coat covering the conjunctiva and the corneal surface of the eye forms the basis for ocular mucoadhesion. These systems markedly prolong the residence time of a drug in the conjunctival sac, since clearence is now controlled by the much slower rate of mucus turnover rather than the tear turnover rate. But improving the corneal drug retention alone is inadequate in bringing about a significant improvement of drug bioavailability. Another approach consists of transiently increasing the pentration characteristics of the cornea with appropriate substances, known as penetration enhancers or absorption promoters. The main aim of this article is to give an insight into the potential application of mucoadhesives and corneal penetration enhancers for the conception of innovative opthalmic delivery appraoches, to decrease the systemic side effects, and create a more focused effect, which may be achieved with lower doses of the drug. Ophthalmic formulations based on these mucoadhesives and penetration enhancers are simple to manufacture and exhibit an excellent tolerance when administered into the cornea. The use of the former considerably prolongs the corneal contact time and the use of the latter increases the rate and amount of drug transport. The various corneal epithelial barriers along with the major routes of transport of drugs are discussed. The article includes a list of the various substances in use or under investigation for the aforementioned properties, along with their mechanisms of action. A fair appraisal of the subject with regard to these two therapeutic approaches and any expected ill effects has been made.